Brigham Buhler: The Peptide Safety Data Reveals 75,000+ Patients With Zero Adverse Events |TUH #182

About this video

Recorded at the White House, Brecka interviews peptide-industry figure Brigham Buhler about peptide access and regulation. Buhler states regulators restricted many peptides for lack of safety data rather than demonstrated harm, and claims his network’s large patient experience showed no adverse events, while both men argue peptides work by prompting the body’s own processes and should be judged alongside proactive biomarker testing, whole-food diet and exercise. They also discuss GLP-1 drugs as one tool among many and AI-assisted analysis of blood work and wearable data.

Key takeaways

• Buhler claims peptide restrictions reflected missing data and poor information, not proven harm.
• Brecka argues peptides are amino-acid sequences the body recognises and can break down.
• Both speakers state GLP-1 drugs without diet and lifestyle change are counterproductive.
• Buhler presents AI modelling of biomarkers as the future of preventive screening.

Episode details: published July 10, 2025 · 176.4K views · 22:40 long. Summary written by Self Growth Videos from the episode itself. Gary Brecka is a commercial health figure, not a physician. The claims described are Brecka’s or his guests’, presented for education — not medical advice and not endorsed by Self Growth Videos. Consult a qualified professional before changing your own health practices.

← Previous: Dr. Daniel Pompa: How Heavy Metal Poisoning Destroys Your Health · Next: Joe Rogan: On Trump Interview, Media Manipulation, UFC Journey, & DeExtinction | TUH #183 →

All Gary Brecka videos · Gary Brecka profile · The Ultimate Human (official site)